Transcatheter sapien valve implantation in a native tricuspid valve after failed surgical repair

Kefer, Joëlle; Sluysmans, Thierry; Vanoverschelde, Jean-Louis

doi:10.1002/ccd.25330

Cited by 35 publications

(15 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Percutaneous tricuspid valve replacement (TVR) can be a feasible treatment for high‐risk patients with severe symptomatic TR that recurs after surgery . There is limited experience with percutaneous interventions for this valve, with small case series of percutaneous TVR on patients with prior surgical TVR or conduits , and few case reports on patients with prior tricuspid valve repair .…”

Section: Discussionmentioning

confidence: 99%

Percutaneous tricuspid valve‐In‐ring replacement for the treatment of recurrent severe tricuspid regurgitation

Condado

Leonardi

Babaliaros

2015

Cathet Cardio Intervent

View full text Add to dashboard Cite

Percutaneous tricuspid valve-in-ring replacement can be an alternative to surgery for high-risk patients with symptomatic severe tricuspid regurgitation that recurs after surgical ring repair. Practitioners must pay attention to the specific technical details associated with this procedure that include: using the ring as a fluoroscopic landmark, sizing the valve area with multi-modality imaging, choosing the appropriate device based on the patients anatomy, and dealing with the inevitable paravalvular leak (created by the ring deformation in the absence of valve-specific devices). Our case demonstrates that percutaneous tricuspid valve-in-ring replacement is a feasible treatment that can result in both hemodynamic and symptomatic improvement.

show abstract

Section: Discussionmentioning

confidence: 99%

Percutaneous tricuspid valve‐In‐ring replacement for the treatment of recurrent severe tricuspid regurgitation

Condado

Leonardi

Babaliaros

2015

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…We were able to find only one report of Edwards Sapien valve implantation into a native tricuspid valve; in this case, pre-stenting techniques were used to establish the rigid target zones that are typically needed for successful transcatheter valve implantation. 7 Large registry studies are necessary to further evaluate the usefulness of this procedure. Long-term followup evaluation will ultimately determine the safety and durability of transvenous transcatheter valve-in-valve implantation after bioprosthetic tricuspid valve failure.…”

Section: Discussionmentioning

confidence: 99%

Transvenous Transcatheter Valve-in-Valve Implantation after Bioprosthetic Tricuspid Valve Failure

Mortazavi¹,

Reul²,

Cannizzaro³

et al. 2014

Texas Heart Institute Journal

View full text Add to dashboard Cite

T ranscatheter valve-in-valve implantation has gained substantial momentum as a viable alternative to surgical valve replacement in patients who are thought to be at high risk for adverse perioperative outcomes. Valve-in-valve implantation of the Edwards Sapien ® valve (Edwards Lifesciences Corporation; Irvine, Calif ) in the tricuspid position is a relatively new procedure, and few cases have been reported. We describe the percutaneous delivery of the Edwards Sapien valve across an existing bioprosthetic tricuspid valve in a patient with metastatic testicular cancer who had undergone multiple previous thoracic operations. We discuss the technical aspects of the case and briefly review the usefulness of transcatheter valve-in-valve techniques in the tricuspid position. Case ReportIn June 2013, a 38-year-old man with severe tricuspid stenosis and regurgitation presented with New York Heart Association functional class III right-sided heart failure. His medical history included malignant neoplasm of the testes, for which he had undergone radical left orchiectomy in 1995 at the age of 19 years. That same year, he underwent exploratory laparotomy, left nephrectomy, bilateral pulmonary resections through a median sternotomy, and removal of multiple metastatic lesions. In 1996, he underwent right thoracotomy to remove additional metastases. During this operation, his tricuspid valve was replaced with a 27-mm Carpentier-Edwards ® Perimount ® bioprosthesis (Edwards Lifesciences) because of valvular involvement of the malignancy. He did well until 2009, when he presented with atrial flutter and underwent successful radiofrequency ablation. He emergently presented in 2012 with atrial flutter that was medically managed with success; the treatment included therapeutic oral anticoagulation.The patient had remained free of cancer for more than 15 years. However, in the 2 years before his current presentation, he had become more fatigued, with worsening shortness of breath and peripheral edema. Physical examination and transthoracic echocardiograms revealed severe tricuspid bioprosthesis stenosis with central regurgitation. The mean transvalvular gradient was 13 mmHg and the peak gradient was 22 mmHg (Fig. 1A), with a peak velocity of 2.34 m/s. No evidence of thrombus, vegetation, or abscess was seen. The right atrial cavity was severely dilated, and the Case Reports

show abstract

“…The bioprosthetic valve frame or annuloplasty ring serve as a rigid and fluoroscopically visible landing zone for the new transcatheter valve. We are aware of just a single previous case report of a transcatheter Sapien valve implantation in a native tricuspid valve following multiple failed surgical repairs where an annuloplasty ring was not present . In this report, we describe a second case where a Melody valve was placed in the tricuspid position in a native tricuspid valve following multiple failed surgical repairs without the presence of a supporting annuloplasty ring.…”

Section: Introductionmentioning

confidence: 92%

Percutaneous melody valve implantation in a native tricuspid valve following failed surgical repair

Sumski

Bartz

Gudausky

2018

Cathet Cardio Intervent

View full text Add to dashboard Cite

Transcatheter valve-in-valve and valve-in-ring implantation has become a common approach to treating patients with failed bioprosthetic tricuspid valves as well as failed surgical repairs of the tricuspid valve where an annuloplasty ring has been utilized. We describe a case where a Melody valve was percutaneously implanted in a native tricuspid valve with severe stenosis following surgical repair without a supporting annuloplasty ring. K E Y W O R D Scongenital, melody valve, pediatric, tricuspid

show abstract

Transcatheter sapien valve implantation in a native tricuspid valve after failed surgical repair

Cited by 35 publications

References 4 publications

Percutaneous tricuspid valve‐In‐ring replacement for the treatment of recurrent severe tricuspid regurgitation

Percutaneous tricuspid valve‐In‐ring replacement for the treatment of recurrent severe tricuspid regurgitation

Transvenous Transcatheter Valve-in-Valve Implantation after Bioprosthetic Tricuspid Valve Failure

Percutaneous melody valve implantation in a native tricuspid valve following failed surgical repair

Contact Info

Product

Resources

About